Furthermore, as reported by Baldacci et al. [25], α-syn/Aβ and α-syn/tau heterodimers in AD RBCs can differentiate between AD patients and healthy subjects, whereas RBC α-syn concentrations alone cannot. Here, MAPT is linked to Alzheimer disease.